Singapore markets close in 51 minutes
Straits Times Index
3,267.09 +41.92 (+1.30%) Nikkei
37,552.16 +113.55 (+0.30%) Hang Seng
16,818.86 +307.17 (+1.86%) FTSE 100
8,059.12 +35.25 (+0.44%) Bitcoin USD
66,153.07 +42.40 (+0.06%) CMC Crypto 200
1,394.43 -20.33 (-1.44%)
ABBV Jun 2024 160.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:35PM EDT. Market open.
| Previous close | 12.00 |
| Open | 12.25 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 160.00 |
| Expiry date | 2024-06-21 |
| Day's range | 12.00 - 12.25 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksAbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Investor focus is likely to be on the sales of AbbVie's (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports first-quarter results.
ZacksEarnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksPharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
© 2024 Yahoo. All rights reserved.